These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3099121)

  • 1. [Morbidity of schistosomiasis in Brazil. IV--Course in treated patients and their controls].
    dos Santos ML; Coura JR
    Mem Inst Oswaldo Cruz; 1986; 81(1):53-60. PubMed ID: 3099121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oxamniquine, praziquantel and a combination of both drugs in schistosomiasis mansoni in Brazil.
    Zwingenberger K; Queiroz JA; Poggensee U; Alencar JE; Valdegunas J; Esmeralda F; Feldmeier H
    Rev Inst Med Trop Sao Paulo; 1987; 29(5):305-11. PubMed ID: 3136533
    [No Abstract]   [Full Text] [Related]  

  • 3. Repeated mass treatment of schistosomiasis mansoni: experience in hyperendemic areas of Brazil. I. Parasitological effects and morbidity.
    Kloetzel K; Schuster NH
    Trans R Soc Trop Med Hyg; 1987; 81(3):365-70. PubMed ID: 3120363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 13-year follow-up of treatment and snail control in an area endemic for Schistosoma mansoni in Brazil: incidence of infection and reinfection.
    de Lima e Costa MF; Rocha RS; Coura Filho P; Katz N
    Bull World Health Organ; 1993; 71(2):197-205. PubMed ID: 8490983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire.
    Polderman AM; Gryseels B; De Caluwe P
    Trans R Soc Trop Med Hyg; 1988; 82(1):115-6. PubMed ID: 3140441
    [No Abstract]   [Full Text] [Related]  

  • 6. Manson's schistosomiasis in Brazil: 11-year evaluation of successful disease control with oxamniquine.
    Sleigh AC; Hoff R; Mott KE; Maguire JH; da França Silva JT
    Lancet; 1986 Mar; 1(8482):635-7. PubMed ID: 2869344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey on the clinical trial results achieved in Brazil comparing praziquantel and oxamniquine in the treatment of mansoni schistosomiasis.
    de Rezende GL
    Rev Inst Med Trop Sao Paulo; 1985; 27(6):328-36. PubMed ID: 3939162
    [No Abstract]   [Full Text] [Related]  

  • 8. Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.
    Gryseels B; Nkulikyinka L
    Trans R Soc Trop Med Hyg; 1989; 83(2):219-28. PubMed ID: 2514474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Schistosoma mansoni infection with oxamniquine in Riyadh, Saudi Arabia.
    Al-Aska AK
    Trop Med Parasitol; 1985 Dec; 36(4):213-4. PubMed ID: 3937212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three year follow-up of chemotherapy with oxamniquine in a Brazilian community with endemic schistosomiasis mansoni.
    Sleigh AC; Mott KE; Silva JT; Muniz TM; Mota EA; Barreto ML; Hoff R; Maguire JH; Lehman JS; Sherlock I
    Trans R Soc Trop Med Hyg; 1981; 75(2):234-8. PubMed ID: 7303137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind therapeutical evaluation based on the quantitative oogram technique, comparing praziquantel and oxamniquine in human schistosomiasis mansoni.
    da Cunha AS; Pedrosa RC
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):337-51. PubMed ID: 3109000
    [No Abstract]   [Full Text] [Related]  

  • 12. Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.
    Gryseels B; Nkulikyinka L; Coosemans MH
    Trans R Soc Trop Med Hyg; 1987; 81(4):641-4. PubMed ID: 3127965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice.
    Amin AM; Mikhail EG
    J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attempt to control the schistosomiasis transmission by oxamniquine, in an hyperendemic locality.
    Prata A; Bina JC; Barreto AC; Alecrim MG
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):65-72, 182-9. PubMed ID: 7455512
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment.
    Sturrock RF; Bensted-Smith R; Butterworth AE; Dalton PR; Kariuki HC; Koech D; Mugambi M; Ouma JH; arap Siongok TK
    Trans R Soc Trop Med Hyg; 1987; 81(2):303-14. PubMed ID: 3113005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low effectiveness of an oxamniquine and praziquantel combination in the therapy of schistosomiasis mansoni].
    Dietze R; Prata A
    Rev Soc Bras Med Trop; 1986; 19(4):247-9. PubMed ID: 3150592
    [No Abstract]   [Full Text] [Related]  

  • 18. Repeated mass treatment of schistosomiasis mansoni: experience in hyperendemic areas of Brazil. II. Micro-level evaluation of results.
    Kloetzel K; de Azevedo Vergetti AM
    Ann Trop Med Parasitol; 1988 Aug; 82(4):367-76. PubMed ID: 3150917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of specific therapy on the levels of schistosomiasis mansoni infection].
    Alvim Ade C
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():333. PubMed ID: 3151108
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of schistosomiasis mansoni with oxamniquine--five years' experience.
    Kilpatrick ME; Farid Z; Bassily S; El-Masry NA; Trabolsi B; Watten RH
    Am J Trop Med Hyg; 1981 Nov; 30(6):1219-22. PubMed ID: 7325280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.